By Jennifer Nesse – Specialty Pharmacy Times 02/26/2019
“…Affecting approximately 38,000 men annually in the United States, metastatic hormone-sensitive prostate cancer (mHSPC) is a deadly form of cancer. …”
Read the entire article: https://www.pharmacytimes.com/view/trial-improved-survival-for-patients-with-metastatic-prostate-cancer
